Intranasal ketorolac-induced pancreatitis as a complication of modified oral aspirin desensitization in a patient with aspirin-exacerbated respiratory disease

J Allergy Clin Immunol Pract. 2020 Mar;8(3):1147-1148. doi: 10.1016/j.jaip.2019.10.006. Epub 2019 Oct 31.

Authors

Kathleen T Luskin¹, John V Bosso², Ronald A Simon¹

Affiliations

¹ Division of Allergy, Asthma and Immunology, Scripps Clinic, San Diego, Calif.
² Penn Medicine, Penn AERD Center, Philadelphia, Pa. Electronic address: John.Bosso@pennmedicine.upenn.edu.

PMID: 31678291
DOI: 10.1016/j.jaip.2019.10.006

No abstract available

MeSH terms

Anti-Inflammatory Agents, Non-Steroidal / adverse effects
Aspirin / adverse effects
Asthma, Aspirin-Induced* / diagnosis
Desensitization, Immunologic
Humans
Ketorolac
Pancreatitis* / diagnosis

Substances

Anti-Inflammatory Agents, Non-Steroidal
Aspirin
Ketorolac